Some biological parameters have also been described as being associated with a higher risk of a thromboembolic event or stroke in AF patients, such as hypercoagulability evaluated using D-dimer [15] but also inflammatory markers such as CRP [118], as discussed in the first section. This evidence concerns the gene CRP and atrial fibrillation.